1223 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Show Display Options
Rank Status Study
21 Completed Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Device: Mobilaser
22 Completed Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
23 Unknown  Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Conditions: Parkinson Disease;   Parkinsonism;   Seborrheic Dermatitis
Intervention: Drug: Botulinum toxin
24 Active, not recruiting Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Conditions: Progressive Supranuclear Palsy;   Atypical Parkinsonism
Interventions: Drug: Coenzyme Q10;   Drug: CoenzymeQ10
25 Enrolling by invitation Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide Intoxication
Condition: Carbon Monoxide-induced Parkinsonism
Intervention: Drug: 18F-FP-(+)-DTBZ
26 Terminated Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
Conditions: Alzheimer's Disease;   Dementia;   Down's Syndrome
Intervention:
27 Recruiting Parkinsonism in Spinocerebellar Ataxia Type 6
Condition: Spinocerebellar Ataxia Type 6
Intervention:
28 Completed
Has Results
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Condition: Parkinsonian Syndromes
Intervention: Procedure: DaTSCAN SPECT imaging
29 Enrolling by invitation Molecular Analysis of Human Neural Stem Cells
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Procedure: Harvesting of neural stem cells
30 Recruiting Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
Conditions: Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
Intervention:
31 Completed Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
Conditions: Ataxia;   Chorea;   Dystonia;   Parkinsonism;   Fatigue
Intervention: Drug: amantadine sulphate
32 Recruiting Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
Conditions: Neurological Diseases,;   Ischemic Stroke,;   Hemorrhagic Stroke,;   Cerebral Palsy,;   Atypical Parkinsonism
Interventions: Drug: Combination injection of EPO and G-CSF;   Drug: Injection of normal saline
33 Active, not recruiting A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Conditions: Parkinson's Disease;   Primary Parkinsonism;   Lewy Body Parkinson's Disease
Intervention: Drug: 18F-AV-133
34 Recruiting Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
Conditions: Idiopathic Parkinson Disease;   Primary Parkinsonism
Intervention: Drug: Mesencephalic Neuronal Precursor Cells
35 Active, not recruiting Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Conditions: Parkinson Disease;   Gaucher Disease;   Idiopathic Rapid Eye Movement Sleep Disorder
Intervention:
36 Completed Low Dose Apomorphine and Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: apomorphine
37 Completed Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
Conditions: Schizophrenia;   Extrapyramidal Syndrome
Intervention: Drug: Risperidone and Olanzapine
38 Recruiting Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism
Condition: Sialorrhea
Interventions: Drug: Xeomin;   Drug: Placebo
39 Recruiting Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ
40 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years